IL16 and Miyoshi myopathy: We are currently exploring in more detail the downstream elements of IL-16 signaling in order to elucidate the mechanism by which secreted IL-16 affects MAPK and PI3K pathways MM, which have previously been shown to play an important role in in the etiology and maintenance of MM [38–42], rendering them promising therapeutic targets [43].